Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.
about
Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients.Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis.Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysisPrognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
P2860
Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@en
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@nl
type
label
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@en
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@nl
prefLabel
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@en
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@nl
P2093
P2860
P356
P1433
P1476
Circulating CD14+ HLA-DR-/low ...... lular carcinoma after surgery.
@en
P2093
Chun-Yan Zhang
Shuang-Jian Qiu
Xiao-Lu Ma
Xin-Rong Yang
Xing-Hui Gao
P2860
P304
P356
10.1111/HEPR.12831
P50
P577
2016-10-20T00:00:00Z